Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seasol International is a prominent Australian biological company that specializes in the development and manufacture of seaweed-based fertilizers and soil conditioners. Established in 1974, the company utilizes sustainably harvested kelp, specifically Durvillaea potatorum and Ascophyllum nodosum, to create products that enhance plant health, root growth, and resilience to environmental stressors. Seasol's portfolio serves the agricultural, horticultural, and home garden markets, providing organic-based solutions for soil and plant management. In 2022, the company was acquired by DuluxGroup, a subsidiary of Nippon Paint, to bolster its global biologicals and sustainable agriculture offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seasol.